As the programme develops we will be providing delegates with profiles of the speakers they will have the opportunity to see during the conference.
Please visit the site frequently for updates.
Fiona Carragher is the Deputy Chief Scientific Officer for England, supporting the head of profession for the 50,000 healthcare science workforce in the NHS and associated bodies – embracing more than 45 separate scientific specialisms.
A Consultant Clinical Biochemist by background, Fiona has a broad portfolio of policy responsibilities, providing professional leadership and expert clinical advice across the health and care system as well as working with senior leaders within both the NHS England and the wider NHS. She has a particular responsibility to provide clinical advice and professional leadership for pathology within NHS England.
Albert Mifsud Is Consultant Microbiologist with Public Health England at the London Public Health Laboratory. He undertakes his clinical sessions at Whipps Cross University Hospital.
He is President of the British Infection Association (2017-2019).
Elizabeth Cross graduated from Brighton & Sussex Medical School in 2012. She stayed in Brighton and undertook an Academic Foundation Programme where she developed an interest in antimicrobial resistance. Following this Elizabeth spent time training in Public Health, completing an MPH at The London School of Hygiene and Tropical Medicine and becoming a member of the Faculty of Public Health. She has gone on to obtain an NIHR Academic Clinical Fellowship in Infectious Diseases & Microbiology where she is undertaking further research in antimicrobial stewardship and training to become an Infectious Diseases & Microbiology registrar.
She is a Lead Healthcare Epidemiology Consultant for the PHE AMR programme, and Clinical Director for Infection at the Royal Free London. She is Chair English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) oversight group which has developed which robust data on antimicrobial use, resistance and stewardship for us across healthcare settings.
Her main research interests are in outbreak investigation and surveillance and healthcare associated infections and AMR. She is a member of many national expert groups and Chairs the Royal College of Physicians working group on HCAI and sits on the PHE’s HCAI & AMR Programme Board and on the MHRA Expert Advisory Group on Anti-Infectives. She has co-authored more than 100 peer-reviewed publications and is Programme Director for the UCL MSc in Healthcare associated Infection Control.
Susan is the Public Health England theme lead for the Innovations in Behaviour Change theme of the HPRU in HCAI and AMR at Imperial College.
Consultant Microbiologist at Sheffield Teaching Hospitals.
Chair of the Healthcare Infection Society.
Alasdair MacGowan is Professor of Antimicrobial Therapeutics at the University of Bristol and Head of the
Research, Specialist and Reference Services offered by the Department of Microbiology.
He is the lead of antibiotic stewardship and has a clinical interest in antimicrobial chemotherapy, and
treatment of blood stream and bone infection.
Carolyne Horner is the newly appointed Senior Clinical Scientific Affairs Officer at the British Society of
Antimicrobial Chemotherapy (BSAC). Prior to her move to Birmingham, Carolyne trained and worked as
a Clinical Scientist within the Department of Microbiology at Leeds Teaching Hospitals (LTHT) and was
most recently employed by Public Health England (PHE) as the Lead Clinical Scientist for Antimicrobial
Resistance and Surveillance for the Yorkshire and the Humber region. Carolyne’s doctorate thesis
examined the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in care homes for
the elderly and her areas of interest are antimicrobial resistance, healthcare-associated infections and
Dr Gerada is a final year specialist registrar in medical microbiology at Liverpool Clinical Laboratories.
Peter Hawkey started his scientific career as a plant pathologist working at East Malling Research
Station. Following a medical degree and research on gentamicin resistant Klebsiella and Providencia a
lifelong interest in the epidemiology and molecular evolution of plasmid mediated antibiotic resistance
in Enterobacteriaceae was kindled. Current work is centred on CTX-M ESBLs and their evolution and
movement in people across the globe and the environment. He also has projects on carbapenemases
and the largest faecal transplant service for Clostridium difficile infection. He is chair of the BSAC/HIS/BIA
working group on the treatment of infections caused by MDR Gram negative bacteria. He has published
over 250 papers, and lectures extensively.
I studied medicine at the University of Sheffield. After this I did my foundation and core training years in South Yorkshire. I moved to Melbourne for one year and worked as a general medical registrar. I am currently working as a LAS SpR in Infectious Diseases at Sheffield Teaching Hospitals. Prior to this I completed a Tropical Medicine and Hygiene Diploma at Liverpool. I have a keen interest in pursuing a career in infectious diseases and medical microbiology.
Dr Tim Brooks CBE is Head of the Rare and Imported Pathogens Laboratory (RIPL) at Public Health England. RIPL is a WHO collaborating laboratory for High Consequence Pathogens, providing diagnostic and clinical advice for a wide range of unusual bacterial and viral pathogens. Tim is one of the leading partners in the national Imported Fever Service, which combines the clinical skills of the Liverpool and London Tropical Infectious Disease Hospitals with RIPL laboratory services His research interests include diagnostics, disease pathogenesis and the basis of Lyme disease. He led the PHE Ebola laboratories in Sierra Leone during the 2014-5 outbreak.
Ed is a consultant in infectious disease at Heartlands Hospital in Birmingham. He trained in Oxford and South Africa and has interests in tuberculosis, bone and joint infection and antibiotic stewardship.
Deb Mathews received her doctorate of Pharmacy degree from Florida A&M University and has over 25 years of clinical and pharmaceutical executive experience. She spent her early years in clinical practice as research pharmacist in Oncology with the Univ of Miami Hospital and Head of Pharmacy Services / Adherence Manager for the HIV/AIDS program with Jackson Memorial Hospital in Miami. She has worked in several leadership positions with the pharmaceutical industry focused on Medical Affairs, scientific insights, publications and data dissemination. She currently serves as VP, Medical Affairs for Synthetic Biologics, Inc. She is interested in mechanistic methodologies for personalized medicine in AMR and biomarker identification linked to clinical outcomes.
Peter Hawkey started his scientific career as a plant pathologist working at East Malling Research Station. Following a medical degree and research on gentamicin resistant Klebsiella and Providencia a lifelong interest in the epidemiology and molecular evolution of plasmid mediated antibiotic resistance in Enterobacteriaceae was kindled. Current work is centred on CTX-M ESBLs and their evolution and movement in people across the globe and the environment. He also has projects on carbapenemases and the largest faecal transplant service for Clostridium difficile infection. He is chair of the BSAC/HIS/BIA working group on the treatment of infections caused by MDR Gram negative bacteria. He has published over 250 papers, and lectures extensively.
Dr Bridget Atkins is GMC accredited in Microbiology and Infectious diseases. In addition to full time clinical work her roles include;
• Lead physician, Bone Infection Unit (BIU), Oxford University Hospitals NHSFT
• ID/Micro Training Programme Director (HEE Thames Valley)
• Hon Senior Lecturer, Oxford University
She has a major interest in bone and joint infections, including laboratory diagnostic methods, the multidisciplinary management of these complex infections, the patient pathway and the optimal delivery of bone infection services. In addition she helps deliver a high quality bedside consult and stewardship service across the trust working closely with non infection specialists.
Janet Scott is a Clinical Lecturer in Pharmacology and Infectious Disease at the University of Liverpool. Her main research interests are in characterizing Post Ebola Syndrome, and optimizing the doses of therapeutics using pharmacokinetic and pharmacodynamic models for, in particular, anti-Ebola therapeutics, following her role in the 2014-2016 epidemic where she was a clinical lead for Wellcome Clinial drug trials (Brincidofovir, and Convalescent plasma). She will be joining the University of Glasgow in February to continue her research into the dose optimization of antiviral therapeutics. A list of current projects and publications can be found here: https://www.liverpool.ac.uk/translational-medicine/staff/janet-scott/
Ginny has a PhD in Applied Microbiology. Prior to joining PHE, her research focused on the role of the environment in the transmission of foodborne illness (University of Wales; University of Ulster) and healthcare-associated infections (University College London Hospitals). At PHE, research themes include the presence, prevalence and dissemination of waterborne pathogens and how type, level and antimicrobial resistance of these bacteria change over time. She also provides air/water microbiology assistance to nosocomial outbreaks as and when necessary (e.g. the role of heater-cooler units in postsurgical M. chimaera infections).
I am a GP in a deprived community in the Rhondda Valleys and an NIHR Doctoral Research Fellow, using big data to better understand the prevention, treatment and prognosis of urinary tract infection in older people. My main research interest is the use of big data to generate clinically useful evidence that improves patient care.
Jonathan Sandoe is Associate Clinical Professor of Medical Microbiology at the University of Leeds and Honorary Consultant Microbiologist at Leeds Teaching Hospitals NHS Trust. He has a longsrtanding clinical and research interest in antimicrobial stewardship and improving patient outcomes through improved antibiotic prescribing.
Dr Schelenz works as a consultant microbiologist and infection control doctor at the Royal Brompton Hospital in London. Silke is chair of the UK clinical mycology networks/Public Health England, member of the English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR): Antifungal resistance and consumption subgroup (PHE/Department of Health), Council member of the British Society for Medical Mycology, RCPath Specialty advisory committee member and Standards in microbiology steering committee member for setting UK Standard Operating Procedures.
As Senior lecturer at Imperial College London she has an active research group and published extensively in the field of infection, particularly medical mycology and acts as a referee for peer review medical journals and grant awarding bodies.
Dr Sutton became a University Hospital Southampton (UHS) Consultant in 2008. He was one of the principal architects in establishing an Infectious Diseases service at UHS and in introducing Infectious Diseases training to Wessex in 2013. Dr Sutton is one of the national curriculum development co-leads for Infection training (Medical Microbiology, Medical Virology, Infectious Diseases and Topical Medicine). Dr Sutton maintains a strong clinical and research interest in Antimicrobial Stewardship and is the UHS Clinical Lead for the AMR CQUIN.
Dr. Alida Fe Talento is Consultant Microbiologist and Antimicrobial Stewardship Lead at St. James’s Hospital in Dublin. She is also Adjunct Assistant Professor in Clinical Microbiology in the School of Medicine, Trinity College Dublin. She is a graduate of the University of the East RMMMC Medical Centre and a Paediatric Infectious Disease specialist in the Philippines and moved to Ireland in 2003. She completed her Specialty Training in Clinical Microbiology in 2014.
She holds a degree of Doctor of Medicine from University of Dublin, Trinity College from her research work on the “Epidemiology, Diagnosis and Management of Invasive Fungal Disease in Critical Care” completed in 2016. Her research interests are on Aspergillus and Candida infections in critical care patients.
Emma currently works at an Antimicrobial Pharmacist at the Royal Oldham Hospital, a position that she has held for over five years now. As part of this role she works closely with colleagues in microbiology and infection control to promote prudent antimicrobial stewardship practice to ensure that patient’s receive the most appropriate treatment for their condition whilst attempting to minimise adverse effects and the occurrence of health care associated infections.
Qualified from Royal Free & University Medical School in 2005. After completing foundation and core medical training, I undertook a PhD ‘Evaluating Patient Susceptibility in Clostridium difficile infection’ before securing an NIHR ACF in Infectious Disease and Medical Microbiology. My current research interest is addressing the growing problem of Antimicrobial Resistance through improving antibiotic stewardship. This has evolved evaluating the impact of AMS within the NHS and more recently, establishing how AMS can be improved in lower/middle income settings.
Nick Brown is a Consultant Medical Microbiologist at Addenbrooke’s Hospital in Cambridge and an Associate Lecturer at the University of Cambridge. He is employed by Public Health England (PHE) and is currently interim Lead Public Health Microbiologist for the East of England. He is the immediate past President of the British Society for Antimicrobial Chemotherapy (BSAC).
Nick has a career long interest in the use of antibiotics and antibiotic resistance. He was recently appointed Director of the Antibiotic Action initiative of the BSAC. He is also a member of various groups working on the implementation of the strategy to combat antibiotic resistance.
I am an academic trainee in Brighton interested in infectious disease and microbiology. My research has focused on whole genome sequence analysis of the malaria parasite, Plasmodium falciparum, based at the Wellcome Trust Sanger Institute, though I have worked on other pathogens including HIV, E. coli O157 and Trypanosoma brucei. Broadly I am interested in the intersection between genomics, microbiology & parasitology, and global public health.
Charlotte is a second year MIBTP BBSRC funded PhD student at the Institute of Microbiology and Infection, University of Birmingham. Research presented here comes after completion of an internship at the British Society for Antimicrobial Chemotherapy on the use of topical antibiotics to prevent surgical site infections. Her doctoral research now focuses on elucidating the lipid mediated pathogenesis mechanisms of human and bovine tuberculosis.
Fifth year medical student at the University of Cambridge with a keen interest in infection.
Fifth year medical student at the University of Cambridge with a keen interest in infection.
Dr Erasmus Smit, MBChB, FRCPath, is working as a consultant virologist for Public Health England for the past 15 years. He is based at Heart of England and University Hospitals Birmingham NHS Foundation Trusts, both in Birmingham, where he helps to provide a clinical consultation service for viral infections for the West Midlands.
His special interests are HIV diagnosis and monitoring, resistance testing and its interpretation. Apart from being the Birmingham Public Health Laboratory’s Virology and STI lead, he also heads its antiviral resistance testing unit.
Professor Watson is a medical epidemiologist working with Public Health England (PHE). He headed respiratory diseases at PHE (previously the Health Protection Agency) from 1999 to 2013 during epidemics of SARS, avian influenza H5 and H7 and MERS, and the 2009 influenza pandemic. From 2013 to 2017 he was Deputy Chief Medical Officer for England with responsibility for health protection.
Main research interest has been wound infection and the role of topical antimicrobial treatments in managing wounds. In particular, the mode of action of Manuka honey on antibiotic resistant wound pathogens has been investigated in vitro with both planktonic and biofilm cultures. Contributed to several position/consensus documents published by the European Wound Management Association and the International Wound Infection Institute.
I am a Belgium born doctor currently working in the Bristol area as an out of programme SHO. I graduated from Peninsula College of Medicine and Dentistry, in Exeter, in 2014, and then went on to do my Foundation Programme in the Wessex deanery (Bournemouth and Jersey). After completing the Foundation Programme I ventured up to Wolverhampton, where I spent a year as a Clinical Teaching Fellow at New Cross Hospital.
Dr Arias is currently specialising in infectious diseases/microbiology in London, after obtaining his MRCP in 2015 (RCP, Edinburgh). He has an MSc (Colombia) and a PhD (UK) in immunology, and has done research for about 18 years on immune responses to tuberculosis and HIV. He has held several grants including a Wellcome Trust grant in 2002, and has 25 publications in peer-reviewed journals. He has taught immunology to under- and post-graduate students in Colombia and the UK. He has been a peer reviewer for several scientific journals including Journal of Immunology and International Journal of Tuberculosis and Lung Disease.
My special interests lie in critical care infections, antimicrobial resistance and health economics, assessing cost-effectiveness of medical interventions and policy. Additionally, performing evaluations on patient pathways via process mapping, having studied Medical Management, and using lean thinking to minimize costs and incidents.
Professor Peter L Chiodini BSc MB PhD MRCS FRCP (Lond) FRCP (Glasg) FRCPath FFTM RCPS (Glasg), ESCMID Fellow
Peter Chiodini graduated from King’s College London with First Class Honours in Zoology and gained his PhD in Parasitology at the Wellcome Research Laboratories. He then studied Medicine in London before undergoing specialist training in Communicable Diseases in Birmingham. He is Consultant Parasitologist at the Hospital for Tropical Diseases, Honorary Professor at the London School of Hygiene & Tropical Medicine and Director of the Public Health England (PHE) Malaria Reference Laboratory and the PHE Parasitology Reference Laboratory. Professor Chiodini organizes the UK National External Quality Assessment Schemes for Parasitology, is a member of the PHE Advisory Committee on Malaria Prevention in Travellers, the Department of Health Advisory Committee on Dangerous Pathogens, and advises the National Blood Service on the prevention of transfusion-transmitted parasitic infections. He was Dean of the Faculty of Travel Medicine of the Royal College of Physicians and Surgeons of Glasgow (2009 to 2012). He is also a practising clinician at the Hospital for Tropical Diseases, with special interests in malaria and hydatid disease. His research interests include new diagnostic methods for parasitic infections, malaria, Chagas disease and hydatid disease.
Maddie Baxter is a fourth year medical student currently studying at the University of Liverpool. After completion of this year she intends to intercalate in Global Health at the University of Manchester, before returning to complete her undergraduate studies back in Liverpool. For the past two years Maddie has been involved in research into influenza vaccination uptake alongside Caitlin Lythgoe under supervision of Dr. Malcom G Semple, University of Liverpool at Alder Hey Children’s NHS Foundation Trust.
Caitlin Lythgoe is a fourth year Medical Student at the University of Liverpool. Her research interests include public health and health promotion. Caitlin has been focused on influenza vaccination uptake for the past two years, working with Madeleine Baxter under supervision of Dr. Malcolm G Semple, University of Liverpool, at Alder Hey Children’s NHS Foundation Trust.
Dr Berit Muller-Pebody is an Infectious Disease Epidemiologist and currently Head of the Antimicrobial Resistance Section, Healthcare-Associated Infections & Antimicrobial Resistance Department at the National Infection Service, Public Health England (PHE).
Dr Berit Muller-Pebody has a special interest in the surveillance of antimicrobial prescribing and resistance, One Health initiatives, paediatric bloodstream infections and data linkage methods. She is Member of the Oversight Group for the English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR).
Robert West is Professor of Biostatistics at the University of Leeds with an interest in antimicrobial resistance, working with microbiologists at Leeds Teaching Hospital Trust. He has expertise in the analysis of large observational datasets – big data – where with careful analysis, useful information about impacts on AMR can be inferred. He also has an interest in diagnostic testing, for example bacterial versus viral infection.
I completed my undergraduate training at St. George’s, University of London since then I have worked at UCH, North Middlesex University Hospital and the Royal Free Hospital. I am currently working in a research and education role in the ID and microbiology department in the Royal Free looking into outcomes in sepsis at our trust.
Craig is the Lead Nurse for Infection Prevention & Control at University Hospitals Birmingham NHS Foundation Trust and has practices in the specialty for 8 years. Craig lectures on the undergraduate nursing programme and has studied healthcare leadership and infection prevention . Craig’s special interests are C. difficile infection, device related infection prevention and education. Craig is widely published in the field and is a member of the Infection Prevention Society board.
Originally from Shetland, studied at Glasgow University, undertook academic foundation training in Aberdeen and completed Core Medical Training in August 2017 in Liverpool. This interesting case was seen during a rotation in the Tropical and Infectious Diseases Unit at Royal Liverpool University Hospital. With a plan to specialise in Infectious diseases, 2 years out of training have begun with completing the DTM&H in November 2017 and soon volunteering in Blantyre, Malawi.
Craig is Professor of Healthcare Associated Infection and Consultant Microbiologist at Dorset County Hospital. His research interests include mixed species biofilms, in particular the impact that these have on the diagnosis and treatment of infection.
Alan Johnson is Head of the Department of Healthcare-associated Infections and Antimicrobial Resistance at the National Infection Service, Public Health England (PHE). He is the PHE Lead for the NIHR-funded Health Protection Research Unit (HPRU) in Healthcare-Associated Infections and Antimicrobial Resistance at Imperial College London, and is a co-theme lead for the HPRUs at both Imperial College and the University of Oxford. He is a member of the government Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare-Associated Infection (APRHAI) and is a former Editor-in-Chief of the Journal of Antimicrobial Chemotherapy.
Emma undertook her PhD at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme in Malawi, and is currently a NIHR Academic Clinical Lecturer within the Division of Infection and Immunity at UCL. Her research interests are focused on invasive infection in HIV infected adults in low and middle income settings, with a particular interest in bacterial meningitis in sub-Saharan Africa.
Her research aims to explore better understanding of the causes of poor outcome from bacterial meningitis, with a view to improving clinical management and outcome.
I am a Wellcome-funded clinical research fellow working on hepatitis B virus (HBV), in collaboration with centres in southern Africa where the infection is endemic but neglected. The aim is to better characterise epidemiology and characteristics of infection in these populations, and then to identify immunological and genetic correlates of control and clearance. I am also involved in developing new clinical platforms for viral diagnostics, including Illumina and Nanopore-based approaches. I am interested in improving routes of academic publication, data visualization, and teaching, and have recently authored a new textbook ‘Notebook of Tropical Medicine’ (Oxford University Press).
I have a background in nursing, midwifery, infection prevention and control and public health. I am currently lecturing in the School of Public Health, University College Cork. My research interest focuses on the prevention of healthcare associated infection and provision of safe care to patients. I am currently undertaking a PhD with the remit of evaluating the efficacy of observational hand hygiene auditing.
I am an ACCS Anesthetics CT1 working in Acute Medicine in South West London, I am interested in intensive care and pre-hospital medicine. I studied at UCL with a BSc in Clinical Hepatology before completing my foundation years in Brighton/London. I am continuing my studies with a diploma in the medical management of conflict and catastrophes. I enjoy outdoor sports and try to keep up with rowing and cycling while working a busy medical rota.
Consultant Antimicrobial pharmacist at the Royal Cornwall Hospital Trust and chairman of the Trust’s Antimicrobial Stewardship Committee and the South West Antimicrobial Pharmacist Group, secretary to the Cornwall One Health Group and Honorary Research Associate, Division of Infectious Diseases, Imperial College London Imperial College London. I have a keen interest in all areas of antimicrobial stewardship with a research interest in the unintended consequences of antimicrobial stewardship interventions and the identification and de-labelling of patients with a spurious penicillin allergy label.
Tom Rogers is President of the British Society for Medical Mycology. His interests in the field encompass epidemiology, molecular diagnostics, and treatment of invasive fungal infections
I became an orthopedic surgeon in 2000. Already in 1998, my interest in orthopedic infections was awakened during a fellowship in Trondheim, Norway. Since 2006 I have been part of a research team centered in the Costerton Biofilm Centre at Copenhagen University. Since 2004 my clinical work has been focused on chronic wounds and amputations, mainly in Copenhagen Wound Healing Center. Currently I am past-President of European Bone and Joint Infection Society, Chairman of Diabetic Foot Study Group, Nordic Diabetic Foot Task Force and Danish Society of Orthopedic Infections. I am the Secretary of Association of Diabetic Foot Surgeons.
I am a Consultant Physician at Hull and East Yorkshire Hospitals NHS Trust and Honorary Senior Clinical Lecturer with Hull & York Medical School. I am lead Clinician for the Humberside and York HIV Network. I have an active interest in post graduate teaching and am member of the SAC in Infectious Diseases and a MRCP Paces Examiner. Currently I am the Meetings secretary for the British Infection Association. I have an active interest in the use of ARVs in resource poor countries.
Katie Jeffery is a Consultant in Clinical Infection and the Deputy Director for Infection, Prevention and Control for the Oxford University Hospitals NHS Foundation Trust. She is currently the Honorary Secretary of the British Infection Association. Her interests are infection prevention and control, molecular diagnosis, neurological infection, viral hepatitis, and infections in the immunocompromised host.
Jennie Wilson has worked in the field of infection prevention and control for over 30 years, both as an infection control nurse specialist in London teaching hospitals and as a consultant epidemiologist at the Health Protection Agency. She has published extensively on healthcare associated infections and is an author of the Epic National Evidence-based Guidelines for Preventing HCAI in NHS Hospitals in England and Infection Control in Clinical Practice. Her current research interests include the use of clinical gloves and hydration of the frail elderly.
Research and clinical interests focus on antimicrobial stewardship, including antimicrobial resistance and Clostridium difficile infection, and using routine healthcare data for infection epidemiology and to design and evaluate interventions. Her national roles have included Clinical Lead for the Scottish Infection Intelligence Platform (IIP) at NHS National Services Scotland, and Chair of the 2017 Health Protection Scotland CDI Guidance Development Group.
Tim is currently working as a NIHR invention for innovation (i4i) Clinical Research Fellow at the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London. His research interests involve exploring cross-discipline approaches to enhancing antimicrobial stewardship.
Tim is currently involved in a cross disciplinary project exploring the utility of Enhanced, Personalised, and Integrated Care for Infection Management at the Point-of-Care (EPIC IMPOC). This aims to explore the utility of integrating machine learning techniques, rapid diagnostics, and mechanisms for drug dose optimisation into clinical decision support systems to improve infection management in the hospital setting.
Pauline Jumaa qualified at the Medical College of St Bartholomew’s Hospital, University of London in 1987. From 1995-2005 she was a Consultant Microbiologist in London, Europe and the Middle East. In 2005-2016 she was Consultant Microbiologist and Director of Infection Prevention Control at University Hospitals Birmingham and was appointed Consultant and Director of Infection Prevention and Control at Lancashire Teaching Hospitals in 2017. She is a member of the International Editorial Board of the Journal of Hospital Infection, chairs a working party of the British Burn Association and Healthcare Infection Society and is a lead examiner for the Royal College of Pathologists.
Niki started her nursing career at the Hospital for Tropical Diseases, London. She then did stints in Neuro Intensive Care at St George’s and as a tuberculosis CNS for South West London. Niki moved into flight nursing in 2010 and eventually became Head of Medical Services for AXA travel insurance. Niki is now the IPC Lead for Virgincare in Surrey & Kent.
Professor Mark Wilcox is a Consultant Microbiologist, Head of Microbiology Research and Academic Lead of Pathology at the Leeds Teaching Hospitals (LTHT), Professor of Medical Microbiology at the University of Leeds (Leeds Institute of Biomedical and Clinical Sciences), and is the Lead on Clostridium difficile and Head of the UK C. difficile Reference Laboratory for Public Health England (PHE). He has formerly been the Director of Infection Prevention (4 years), Infection Control Doctor (8 years) and Clinical Director of Pathology (6 years) at LTHT.
Professor Wilcox is Chair of Public Health England’s Rapid Review Panel (reviews the utility of infection prevention & control products for the NHS), Deputy Chair of the UK Department of Health’s Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Committee and is a member of the PHE’s Programme Board on Healthcare Associated Infection & Antimicrobial Resistance. He is a member of the Medical Research Council’s Infections and Immunity Board. He is an advisor to the Department of Health in England on healthcare associated infections (HCAIs), the UK EPIC/NICE projects, the Health Technology Assessment (HTA) programme on Healthcare Associated Infection, the Wellcome Trust on novel antimicrobials, and the European Centre for Disease Control. He is a member of UK, European and US working groups on C. difficile infection, and is on the Editorial Boards of Lancet Gastroenterology & Hepatology, Journal of Hospital Infection and Infectious Diseases in Clinical Practice. He has provided clinical advice as part of the FDA/EMA submissions for the approval of several novel antimicrobial agents, 1998-2016.
Professor Wilcox heads a Healthcare Associated Infection research team at the University of Leeds, comprising ~30 doctors, scientists and nurses; projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, staphylococcal infection, and the clinical development of new antimicrobial agents. He has a track record of translational research, including providing the basis of clinical advice to the NHS. He has been the Principal/UK Investigator for 14 clinical trials of new anti-infective drugs, 1999-2016, has carried out multiple NIHR portfolio studies on healthcare associated infection topics, and is currently supplying central laboratory services for several clinical trials of antimicrobial agents. He has authored >430 papers and published a number of books and chapters. He is co-editor of Antimicrobial Chemotherapy (5th/6th/7th Eds, 2007/12/15).
Heather Loveday is Professor of Evidence-based Healthcare and Director of Research in the College of Nursing, Midwifery and Healthcare at the University of West London and leads the Richard Wells Research Centre. She is the immediate past-President of the Infection Prevention Society.
Heather is a recognised leader in the field of infection prevention and control and patient safety having been at the forefront of translational research for the past 20 years. She is the lead author of the Epic3 national evidence-based guidelines for the prevention of HCAI in England and has been involved in the development and evaluation of national IPC policy implementation strategies. Her guiding passion is influencing and developing practice and capacity in infection prevention and control through research, innovation, education and improvement science.
Elizabeth Beech currently works as one of three English national project leads for Healthcare Acquired Infections and Antimicrobial Resistance within the Patient Safety Domain at NHS Improvement - supporting the implementation of the UK Antimicrobial Resistance Strategy, in particular within primary care. Elizabeth also works as a pharmacist in NHS Bath and North East Somerset CCG, participates in AMR related research, and is a member of the Q community. Elizabeth set up #ToDipOrNotToDip community of interest to improve the management of UTI in care homes- contact Elizabeth.beech@nhs to join
Ciara Cox graduated with a Biological Sciences degree (BSc) in 2011 and with a Doctor of Philosophy (PhD) in 2014 from Queens University Belfast. She currently works in Regional Virus Laboratory, Belfast as Research Fellow for QUB whilst nearing completion of her Microbiology Clinical Scientist training. Her research interests include – emerging sexually transmitted infections, vaginal microbiome studies in pregnant and non-pregnant women and the effect on preterm birth. Ciara has a keen interest in improving diagnostics in these areas, where she works closely with clinical groups at Royal Victoria Hospital and has published her work in international peer reviewed journals.
Matthew Dryden is a consultant in infection at the Hampshire Hospitals Trust in Winchester, and the Rare and Imported Pathogens Department, PHE and an honorary senior lecturer at Southampton University Medical School, UK. He is a visiting Professor at St George’s University School of Medicine in Grenada, West Indies, and consultant to the Falkland Islands and St Helena Governments Health Services. He is recent past General Secretary of the British Society for Antimicrobial Chemotherapy, a member of the executive committee of the International Society of Chemotherapy and a Fellow of the Royal Geographical Society.
Consultant in Clinical Pathology in Portugal, moved to the UK in 2015 to broaden her experience in Clinical Microbiology. Worked as a Senior Clinical Fellow at the Microbiology Department of the Royal Free Hospital NHS FT until August 2017.
Dr Nicholas Reid is the lead antimicrobial pharmacist for Wales, hosted by Public Health Wales. He is the professional lead for the antimicrobial pharmacy teams across Wales and supports the Antimicrobial Resistance Implementation Group (AMRIG) and its work streams. He leads on the audit work programme, and has a strong interest in the ongoing development of prescribing indicators and educational resources. He is also a dedicated family man and proud father, which drives his passion to preserve antimicrobials for the future.
Dr Sanjay Patel is a paediatric infectious diseases and immunology consultant working at Southampton Children’s Hospital, England. His main areas of interest are OPAT and antibiotic stewardship:
In 2012, he introduced the first paediatric outpatient parenteral antibiotic therapy (p-OPAT) service in the UK. He chaired the joint BSAC / British Paediatric Allergy, Immunology and Infectious Diseases Group p-OPAT national working group tasked to develop good practice guidelines for the introduction and delivery of p-OPAT services in the UK, which were published in October 2014.
He leads the antimicrobial stewardship service at Southampton Children’s Hospital and was a member of the NICE antibiotic stewardship guideline development group which published guidelines in 2015. He is on the BSAC OPAT standing committee and sits on BSAC council. He is co-lead for the module on antimicrobial stewardship for the ESPID on-line antibiotic management course and runs infectious diseases courses at Imperial College and in Iceland. As project lead of Healthier Together Wessex, he is working with primary care colleagues to improve antibiotic prescribing in community based settings (www.what0-18.nhs.uk).
Stephen has a long-standing interest in tropical medicine and international child health. He was recently appointed to the UK Emergency Medical Team, providing clinical support to countries afflicted by sudden onset disasters. At home, Stephen is helping to develop Newcastle’s clinical service for patients with High Consequence Infectious Diseases such as the Viral Haemorrhagic Fevers. He is an examiner for the Royal College of Physicians’ Diploma in Tropical Medical and Hygiene and Co-President of the Paediatrics in the North: Global Health Society (PiNGHS).
Professor Keith Harding CBE FRCGP FRCP FRCS FLSW, Dean of Clinical Innovation at Cardiff University and Medical Director of the Welsh Wound Innovation Initiative has had a longstanding interest in wound healing. He was appointed as the first Director of the Wound Healing Research Unit in 1991. From 2011 – 2013 he was Director of TIME Institute and Head of Wound Healing Research Unit, School of Medicine, Cardiff University and Clinical Lead for Wound Healing in the Cardiff & Vale NHS Trust. His clinical practice is exclusively focused on treating patients with wound healing problems with a wide range of aetiologies. In 2013 he was awarded £4.2 million to set up the Welsh Wound Innovation Initiative. He was awarded the CBE in the New Year Honours list in January 2013.
Dr Elizabeth Johnson has worked in the field of medical mycology for more than 30 years, first for the National Health Service and latterly the Public Health Laboratory Service, Health Protection Agency and Public Health England (PHE). For the last 15 years she has been director of the PHE National Mycology Reference Laboratory and curator of the UK National Collection of Pathogenic Fungi. She has a great interest in the identification, diagnosis and treatment strategies for all pathogenic fungi.
Professor Wei Shen Lim is a consultant respiratory physician at Nottingham University Hospitals NHS Trust and Honorary Professor of Medicine, University of Nottingham. He is a member of the New and Emerging Respiratory Viral Threats Advisory Group (NERVTAG) to the Chief Medical Officer. He was Chairman of the British Thoracic Society (BTS) Community Acquired Pneumonia Guidelines committee and Chairman of the BTS Respiratory Infection Specialist Advisory Group. His research centres on clinical and epidemiological aspects of respiratory infections, particularly pneumococcal pneumonia , influenza and community acquired pneumonia.
Dr Tunbridge has been a consultant Infectious Diseases physician at Sheffield Teaching Hospitals since 2006. Her interest in safe management of high risk imported infections began after working in Toronto during the SARS outbreak in 2003. She sits on the Advisory Committee for Dangerous Pathogens and was involved in rewriting the Viral Haemorrhagic Fever assessment algorithms and management pathway. In 2014, the Sheffield ID unit was designated as one of four UK Ebola surge capacity centres. Dr Tunbridge was the clinical lead for this project and subsequently became involved with the ‘High Consequence Infectious Disease (HCID)’ programme.
Dr Simon Goldenberg is a Consultant Microbiologist and Infection Control Doctor at Guy’s & St. Thomas’ NHS Foundation Trust and Infection Control Advisor at Moorfields Eye Hospital NHS Foundation Trust. He is also Honorary Senior Lecturer at King’s College, London. He completed his MD thesis on the molecular epidemiology and diagnostic testing of Clostridium difficile. His main interests are health-care associated infections (particularly C. difficile), development of novel molecular diagnostics and point of care / near patient testing. He is an assistant editor of the Journal of Hospital Infection and a trustee and council member of the Healthcare Infection Society.
I am a Higher Specialist Trainee in Microbiology and have recently started the HSST programme. I graduated from Newcastle University with a degree in Medical Microbiology and Immunology. I started as an Associate Practitioner in the Microbiology department at the Great Western Hospital, Swindon before training to be a Biomedical Scientist and then a Specialist Biomedical Scientist. I joined the STP in 2012 which involved a move to Lancashire Teaching Hospitals NHS Foundation Trust, Preston. On completion of the STP in 2015 I registered as a Clinical Scientist and worked in this role prior to starting the HSST.
Steve Taylor is the Lead Consultant for Birmingham Heartlands HIV Service, Honorary Senior Clinical Lecturer at the University of Birmingham,and Medical Director of the National Saving Lives Charity. He is on the BHIVA Executive committee and an active member of the National NHSE HIV CRG Antiretroviral Sub-group. He is the Research Lead for the Birmingham Heartlands HIV Service and Primary Investigator on numerous on going HIV/Hepatitis clinical trials. His research interests are in the efficacy and Clinical Pharmacology of HIV/Hepatitis Antiviral Therapy, Sexual Transmission of HIV and Testing Strategies for HIV and Viral Hepatitis.
Stéphane Paulus is a consultant in Infectious Diseases at Alder Hey Children's Hospital in Liverpool, UK and Honorary Senior lecturer at the Institute of Infection and Global Health, University of Liverpool. He is the convener of the British Paediatric Allergy, Immunology and Infection Group (BPAIIG). Stéphane has established the p-OPAT and Antimicrobial Stewardship programmes at Alder Hey Children’s Hospital in 2014. His research interests include antimicrobial resistance, stewardship and infections in haemato-oncology patients.
Cairine is Lead Antimicrobial Pharmacist for Western Health and Social Care Trust, and Chair of the Northern Ireland Antimicrobial Pharmacist Network. Cairine graduated from Queen’s University Belfast in 1998 and has completed an MSc Clinical Pharmacy (2006) and MSc in Infection Management for Pharmacists (2015). Cairine’s project “Enhancing the Clinical Review of Antimicrobial Therapy by Pharmacists” was shortlisted for the Northern Ireland Safety Forum awards in 2016. Cairine interests include Outpatient Parenteral Antimicrobial Therapy and had an e-Poster evaluating the integration into the Rapid Response team displayed in ECCMID 2017. Cairine supervises University of Ulster Undergraduate student research projects.
Dr Mitul Patel is a consultant microbiologist at Birmingham Women’s and Children’s NHS Foundation Trust. His interests are infections in childhood, maternal infections, infections in paediatric liver, small bowel and bone marrow transplants, rational and rapid diagnosis and its impact on clinical management of infection. He is chair for the West Midlands Infection Group (a local chapter of British Infection Association). He is an educational supervisor for infection trainees and a member of the regional infection training committee.
Adam studied in Birmingham before completing subspecialty training in Paediatric Infectious Disease in London. He received his PhD from the University of Liverpool, where he researched the diagnosis of serious infection in children. He retains an interest in diagnostics, particularly of invasive infections in the immunocompromised child, and in antimicrobials. Following another suboptimal cricketing summer, Adam is joining the University of Queensland in 2018.
Dr. Nicky Connor leads the monitoring of HIV testing for the HIV &STI Department at Public Health England. Last year she produced England’s first HIV testing report, providing a single source of national data. She was a member of the NICE quality standards group for HIV testing. Nicky also leads the surveillance data for the National Chlamydia Screening Programme. Prior to this Nicky was Assistant Director of the PHE Centre for Infectious Disease Surveillance, responsible for Official Statistics and surveillance evaluation.
GB qualified in Medicine at Leicester University and trained in infectious diseases and internal medicine in Leeds, Sheffield and Dundee, including a two-year research fellowship leading to MD at the University of Dundee. GB’s main clinical interests are orthopaedic infection, outpatient parenteral antibiotic therapy (OPAT), and the management of complex bacterial. He has been a consultant in infection at Hull & East Yorkshire Hospitals NHS Trust since 2004 and is trust lead for antimicrobial stewardship. Research interests are broad, but predominantly focus on the epidemiology and clinical care of infections common in the NHS. He is the BSAC officer for stewardship and surveillance.
I have been working as a consultant in York for the past year. Before that I trained in Microbiology and Infectious Diseases in Leeds. During that time I undertook research in to Clostridium difficile transmission and diarrhoea in hospitals. The HOODINI project was part of that work, which I was funded to do by a Healthcare Infection Society Fellowship.
Dr Nick Larbalestier has been the lead clinician at the Guy’s and St. Thomas’ HIV service for the past 14 years. His special interests include HIV in-patient care, HIV / TB co-infection and HIV renal disease and transplantation.
James McIlroy is a final year medical student at the University of Aberdeen and CEO of EnteroBiotix, a biotechnology company that is developing an orally administered encapsulated microbial product for use in Faecal Microbiota Transplantation. Alongside his studies, he has raised over £700k in funding for the company and has established a state of the art GMP-compliant manufacturing facility within the Aberdeen Blood Transfusion Centre. He was awarded an Enterprise Fellowship by the Royal Society of Edinburgh in 2016 and a Visiting Research Fellowship by United European Gastroenterology in 2017.
Jordan has been involved in the National Infection Trainee Collaborative for Audit and Research (NITCAR) since its inaugural meeting, and currently sits on its management committee. After completing a PhD in theoretical particle physics, he retrained in medicine, and currently holds a NIHR Academic Clinical Fellowship with basic science research interests in mathematical pathogen genomics, in addition to being involved in a number of clinical projects. He practises in Cambridge as a registrar in infectious diseases and medical microbiology.
Dr Harriet Hughes is a consultant in Infectious Diseases and Microbiology at the University Hospital of Wales, Cardiff. She trained initially in Oxford before moving to Cardiff to complete her training. She is the Clinical Lead for the UK Anaerobe Reference Unit, providing advice on the clinical management of anaerobic infections across the UK. She supports the research output of the unit including the ongoing surveillance of antimicrobial resistance in clinically relevant anaerobic pathogens, and the development of genomic diagnostics. She also has a special interest in bone and joint infection, and has developed and leads the Microbiology-Orthopaedic liaison service in Cardiff which deals with complicated infection on a tertiary basis. She leads on post-graduate training for microbiology and infectious diseases trainees in Wales, is Deputy Programme Director and an Educational Supervisor.
Hilary Humphreys is Professor of Clinical Microbiology at the Royal College of Surgeons in Ireland and Consultant Microbiologist in Beaumont Hospital, Dublin. He has a longstanding research interest in hospital infections, and he has led guideline groups in Ireland and in the UK on MRSA. Amongst his research interests are the factors that reduce post-operative infections arising from the surgical procedure.
I graduated from the University of Leeds Medical School in 2010. I then did my foundation years and core medical training in Sheffield. In 2016 I started specialist training in Microbiology at Leeds Teaching Hospitals. I am currently taking time out of training to complete a 1 year clinical research fellowship where I am conducting a feasibility trial on antibiotic duration in complicated intra-abdominal infections.
Rosamund Southgate is a public health doctor at the humanitarian medical relief charity Médecins Sans Frontières (MSF) in London, UK.
With the MSF team of epidemiologists, GIS and eHealth specialists she is working to enhance evidence based and data-driven decision making in humanitarian response. This includes improving outbreak management systems, greater use of technology in the field, bringing a public health approach to field work and strengthening clinical governance.
Rosamund has worked for MSF in Sierra Leone during the Ebola outbreak, Syria, South Sudan, Ethiopia and Democratic Republic of the Congo. She has previously worked with the UK NHS, Public Health England, the United Nations Disaster Risk Reduction platform and the WHO.
Lim Jones currently provides clinical cover for PHW microbiology laboratories in Swansea and Cardiff, including the Specialist Antimicrobial Chemotherapy Unit. His main areas of clinical and academic interest are antimicrobial resistance, susceptibility testing and antimicrobial stewardship. He completed a PhD at Cardiff University on antimicrobial resistance and has published book chapters, reviews and original articles on the topic.
Irasha graduated from the University of Bristol in 2009 and is currently a final year registrar in Medical Microbiology in Cardiff. Her special interests include Cystic Fibrosis Microbiology and Orthopaedic infections. Irasha is also the Regional Healthcare Infection Society (HIS) trainee representative for Wales.
Reader and Honorary Consultant in Infectious Diseases at Cardiff University and University Hospital of Wales. He qualified in Medicine from Cambridge University & St Thomas’ Hospital in 1980, and subsequently trained in Infectious Diseases at St George’s Hospital, London and Harvard Medical School, USA, before moving to Cardiff in 1994. He is a member and previous chair of the British HIV Association Audit & Standards sub-committee, and a previous member of the DH Expert Advisory Group on AIDS.
Dame Sally is the Chief Medical Officer for England and Chief Medical Advisor to the UK Government. She is an independent advisor to the UK Government on medical and public health matters.
Dame Sally founded the National Institute for Health Research and is a Non-Executive Director of Genomics England Ltd. She was a member of the WHO Executive Board and the Strategic and Technical Advisory Group on AMR. Most recently, she has been appointed a co-convener of the UN Inter-Agency Co-ordination Group on AMR, set up in response to the UNGA 2016 declaration.
Dame Sally received her DBE in 2009, was elected Fellow of the Royal Society in 2014, and a member of the National Academy of Medicine, USA in 2015.
Commenced Infection training at UHW in 2015.
Recent winner of the junior investigator price at the Welsh microbiology association summer conference.
Gavin trained in microbiology in Cardiff and Newport, and has recently been appointed to his first consultant position in Cardiff.
His clinical interests include paediatrics, C.difficile-associated diarrhoea and infection prevention and control.
Alongside his clinical role Gavin is also the Infection Prevention and Control Doctor for Powys Teaching Health Board.
Sheila graduated BSc in Microbiology, 1977 and PhD, 1981 from University of Edinburgh. She relocated to Queen’s University Belfast with her PhD supervisor, continued in Post-doctoral Research and Lectureship posts at Queen’s University and was appointed Professor in 2005. In 2006 she graduated DSc from Edinburgh University. Sheila’s research focuses on bacteria of the normal resident microbiota of the gastrointestinal tract and the skin, in the context of anaerobic post-surgical and implant associated infection. Her research includes bacterial genome analysis to inform understanding of virulence and antimicrobial resistance; she was PI on the first Bacteroides fragilis genome sequencing project in 2000. In 1998 her group reported the importance of Propionibacterium acnes in chronic implant infection and prosthetic joint failure. Her research showed that anaerobic handling and ultrasound treatment of retrieved implants is necessary for accurate diagnosis. She has recently published an RCT which showed a significant improvement to spinal surgery disinfection by sequential use of alcoholic povidone iodine and chlorhexidine gluconate compared to the use of povidone iodine alone. Sheila is currently a Visiting Researcher at Edinburgh University. She is Chair of the Society for Anaerobic Microbiology Council, Chair-elect (2018) for the Microbiology Society Prokaryotic Division and the Microbiology Society representative for FIS.
Nigel Gibbens is the UK’s Chief Veterinary Officer. He was appointed in May 2008 following previous experience in the State Veterinary Service and in policy roles on international trade, BSE controls, animal welfare and international relations co-ordination for Defra’s Food and Farming Group.
Prior to joining the UK government services in 1990, Nigel worked in private practice in his early career and in Government veterinary services in Belize and Yemen.
Nigel enjoys cycling, walking, at home and abroad, gardening and DIY.
Nigel holds an Honorary Professorship from the Royal Veterinary College. He was appointed Commander of the Order of the British Empire (CBE) for services to the veterinary profession and animal welfare in the New Year’s Honours list for 2016
Mary trained in the West Midlands before taking up her first consultant post at New Cross Hospital Wolverhampton in 2009. She is now based at Worcester NHS Trust as a consultant microbiologist sharing the roles of Co-Laboratory Director and Infection Control Doctor with her colleague. She has had extensive involvement in water related incidents during her time as a registrar and consultant including management of water related Pseudomonas aeruginosa outbreaks, writing Trust Water Safety Plans, ensuring the provision of safe water in new builds and refurbishments and is a key member of the Worcester Hospital Water Safety Committee.
Previously Consultant microbiologist and DIPC at University Hospitals Coventry and Warwickshire during the construction of the new hospital (part opened in 2005) which at the time was the largest PFI build in Europe. It was during this process that my interest in water microbiology emerged.
Nick’s interest is to show how health services can be improved at low cost, or even improved with cost savings. And he likes simple but important research. He has received more than $25M in research funding since 2004, mostly from international and national competitive schemes. He gained his PhD in Economics from the University of London, spent 10 years as Lecturer and Research Fellow with the Health Services Research Unit at the London School of Hygiene and Tropical Medicine, and is currently Professor of Health Economics at Queensland University of Technology.
Mark was awarded a PhD from the University of Birmingham after studying antimicrobial resistance in Streptococcus pneumoniae’ in the laboratory of Professor Laura Piddock.
Mark has worked in the field of Infection Control for over 8 years; previously working at the Royal Wolverhampton NHS Trust and NBT.
Mark moved to the University Hospitals Birmingham NHS Foundation Trust in 2013 working as a Clinical Scientist within the Infection Prevention and Control team.
Mark is currently working as a Principal Clinical Scientist in Microbiology and Associate Director of Infection Prevention and Control (ADIPC).
In 2017 Mark also took up the role as Director of the Hospital Infection Research Laboratory; with the main function to investigate hospital infection, providing practical advice to Health service professionals and industry throughout the UK.
Mark’s current research interests include water microbiology focusing on Pseudomonas aeruginosa and Mycobacterium chimaera; general Infection Prevention and Control issues from MRSA to Carbapenemase Producing Enterobacteriaceae.
Dr Jacqueline Sneddon is Project Lead for the Scottish Antimicrobial Prescribing Group (SAPG) which is a national clinical multi-disciplinary forum that leads the national antimicrobial stewardship programme. She is a Fellow of the Faculty of the Royal Pharmaceutical Society (RPS) and Chair of the UKCPA Pharmacy Infection Network. Within SAPG Jacqueline has led development of education resources on antimicrobial stewardship, prescribing quality indicators, development of national consensus on antimicrobial policies and initiatives to improve the use of antimicrobials in Care Homes and recently development of a national antimicrobial app.
Prof. Dilip Nathwani is Consultant in Infectious Diseases and Honorary Professor of Infection at the University of Dundee. He is President of the British Society for Antimicrobial Chemotherapy, past- Chairman of the Scottish Antimicrobial Prescribing Group; Chair of the European Study Group on Antibiotic Policies and. He is also co-Director of Tayside Academic Health Sciences Partnership with interest in education and quality improvement; National Specialty Adviser for Infectious Diseases to the Scottish Government Health Department and Programme Director of the Global Antimicrobial Stewardship Massive on line course [MOOC]. Professor Nathwani has authored more than 225 peer-reviewed publications and contributed extensively to national and international infection guidelines. His research interests include developing and promoting best infection practice guidelines, anti-microbial stewardship, medical education, quality improvement in infection management, clinical and health economic outcomes in relation to new antibiotics, particularly those related to the treatment of serious and resistant pathogens such as MRSA and C.difficle: Contact: email@example.com